Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer
Tanaka, K.
Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
1989
ISSN/ISBN: 0047-1860 PMID: 2630676 Document Number: 338033
Document emailed within 1 workday
Related Documents
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Laganà, A.S.; Colonese, F.; Colonese, E.; Sofo, V.; Salmeri, F.M.; Granese, R.; Chiofalo, B.; Ciancimino, L.; Triolo, O. 2015: Cytogenetic analysis of epithelial ovarian cancer's stem cells: an overview on new diagnostic and therapeutic perspectives European Journal of Gynaecological Oncology 36(5): 495-505
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Kiechle-Schwarz, M.; Bauknecht, T.; Schmidt, J.; Walz, L.; Pfleiderer, A. 1995: Recurrent cytogenetic aberrations in human ovarian carcinomas Cancer Detection and Prevention 19(3): 234-243
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Döhner, H.; Stilgenbauer, S.; Fischer, K.; Bentz, M.; Lichter, P. 1997: Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes Leukemia 11(Suppl): S19-S24
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Penault-Llorca, F.; Levrel, O.; Clémenson, A.; Kwiatkowski, F.; Pomel, C.; Fouilhoux, G.; De Latour, M.; Curé, H.; Déchelotte, P.; Fonck, Y.; Dauplat, J. 2000: Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 548-554
Mayer, M.; Kulig, A.; Sygut, J.; Dziki, A.; Simon, D.; Latos-Bieleńska, A.; Ferenc, T. 2007: Molecular cytogenetic analysis of chromosome aberrations in desmoid tumors Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 58(3): 167-171
Kamiński, K.; Putowski, Lław.; Oleszczuk, J. 2003: Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma Ginekologia Polska 74(9): 741-745
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11
Russell, S.E.; Hickey, G.I.; Lowry, W.S.; White, P.; Atkinson, R.J. 1990: Allele loss from chromosome 17 in ovarian cancer Oncogene 5(10): 1581-1583
Phillips, N.J.; Ziegler, M.R.; Radford, D.M.; Fair, K.L.; Steinbrueck, T.; Xynos, F.P.; Donis-Keller, H. 1996: Allelic deletion on chromosome 17p13.3 in early ovarian cancer Cancer Research 56(3): 606-611
Chou, Y-Ching.; Chen, Y-Jen.; Lai, C-Ru.; Wang, P-Hui.; Hsin-Chan; Yuan, C-Chung. 2006: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis European Journal of Obstetrics Gynecology and Reproductive Biology 124(1): 101-105
Fan, R.; Huang, W.; Luo, B.; Zhang, Q.M.; Xiao, S.W.; Xie, X.X. 2015: Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays European Journal of Gynaecological Oncology 36(3): 298-303
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716